Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
13 employees
Benitec Biopharma, a California-based biotech firm, develops novel genetic medicines for chronic, life-threatening conditions.
HQ
Founded
2019
Benitec Biopharma, based in Hayward, California, is a biotechnology firm focused on developing novel genetic medicines and ddRNAi-based therapeutics for chronic and life-threatening conditions such as oculopharyngeal muscular dystrophy (OPMD) and chronic hepatitis B. The company aims to provide innovative treatment options for gene-associated diseases with no current effective treatments.
Benitec Biopharma has made significant strides in the biotech industry with its leading gene therapy capabilities and a highly credentialed scientific and management team. The company's impact is evident in its advanced treatment options and its role in the scientific community, serving customers worldwide.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Genetic Medicines
Technology
Biotech
Tags
Healthtech
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Benitec Biopharma founded?
Benitec Biopharma was founded in 2019.
Where is Benitec Biopharma's headquarters located?
Benitec Biopharma's headquarters is located in Hayward, CA, US.
When was Benitec Biopharma's last funding round?
Benitec Biopharma's most recent funding round was for $3M (USD) in August 2023.
How many employees does Benitec Biopharma have?
Benitec Biopharma has 13 employees as of Feb 6, 2024.
How much has Benitec Biopharma raised to-date?
As of July 05, 2023, Benitec Biopharma has raised a total of $82.3M (USD) since Aug 11, 2023.
Add Comparison
Total Raised to Date
$82.3M
USD
Last Update Aug 11, 2023
Last Deal Details
$3M
USD
Aug 11, 2023
Post Ipo Equity
Current Employees
13
Last updated: Feb 6, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts